Literature DB >> 15989765

Frequency analysis of autosomal dominant spinocerebellar ataxias in mainland Chinese patients and clinical and molecular characterization of spinocerebellar ataxia type 6.

Hong Jiang1, Bei-sha Tang, Bo Xu, Guo-hua Zhao, Lu Shen, Jian-guang Tang, Qing-hua Li, Kun Xia.   

Abstract

BACKGROUND: Dominantly inherited spinocerebellar ataxia (SCA) is a clinically and genetically heterogeneous group of neurodegenerative disorders. This study was to further assess the frequency of SCA1 (spinocerebellar ataxia type 1), SCA2, SCA3/MJD (spinocerebellar ataxia type 3/Machado-Joseph disease), SCA6, SCA7, SCA8, SCA10, SCA12, SCA14, SCA17 and DRPLA (dentatorubro-pallidoluysian atrophy) in mainland Chinese, and to specifically characterize mainland Chinese patients with SCA6 in terms of clinical and molecular features.
METHODS: Using a molecular approach, we investigated SCA in 120 mainland Chinese families with dominantly inherited ataxias and in 60 mainland Chinese patients with sporadic ataxias. Clinical and molecular features of SCA6 were further characterized in 13 patients from 4 families.
RESULTS: SCA3/MJD was the most common type of autosomal dominant SCA in mainland Chinese, accounting for 83 patients from 59 families (49.2%), followed by SCA2 [8 (6.7%)], SCA1 [7 (5.8%)], SCA6 [4 (3.3%)], SCA7 [1 (0.8%)], SCA8 (0%), SCA10 (0%), SCA12 (0%), SCA14 (0%), SCA17 (0%) and DRPLA (0%). The genes responsible for 41 (34.2%) of dominantly inherited SCA families remain to be determined. Among the 60 patients with sporadic ataxias in the present series, 3 (5.0%) was found to harbor SCA3 mutations while none was found to harbor SCA6 mutations. In the 4 families with SCA6, significant anticipation was found in the absence of genetic instability on transmission.
CONCLUSION: A geographic cluster of families with SCA6 subtype was initially identified in a mainland Chinese population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15989765

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  7 in total

Review 1.  Machado-Joseph Disease: from first descriptions to new perspectives.

Authors:  Conceição Bettencourt; Manuela Lima
Journal:  Orphanet J Rare Dis       Date:  2011-06-02       Impact factor: 4.123

2.  Spinocerebellar ataxia: a rational approach to aetiological diagnosis.

Authors:  Adrian Degardin; Dries Dobbelaere; Isabelle Vuillaume; Sabine Defoort-Dhellemmes; Jean-François Hurtevent; Bernard Sablonnière; Alain Destée; Luc Defebvre; David Devos
Journal:  Cerebellum       Date:  2012-03       Impact factor: 3.847

3.  High frequency of Machado-Joseph disease identified in southeastern Chinese kindreds with spinocerebellar ataxia.

Authors:  Shi-Rui Gan; Sheng-Sheng Shi; Jian-Jun Wu; Ning Wang; Gui-Xian Zhao; Sheng-Tong Weng; Shen-Xing Murong; Chuan-Zhen Lu; Zhi-Ying Wu
Journal:  BMC Med Genet       Date:  2010-03-25       Impact factor: 2.103

Review 4.  Founder Effects of Spinocerebellar Ataxias in the American Continents and the Caribbean.

Authors:  Roberto Rodríguez-Labrada; Ana Carolina Martins; Jonathan J Magaña; Yaimeé Vazquez-Mojena; Jacqueline Medrano-Montero; Juan Fernandez-Ruíz; Bulmaro Cisneros; Helio Teive; Karen N McFarland; Maria Luiza Saraiva-Pereira; César M Cerecedo-Zapata; Christopher M Gomez; Tetsuo Ashizawa; Luis Velázquez-Pérez; Laura Bannach Jardim
Journal:  Cerebellum       Date:  2020-06       Impact factor: 3.847

5.  Prevalence rate and functional status of cerebellar ataxia in Korea.

Authors:  Byung-Euk Joo; Chan-Nyoung Lee; Kun-Woo Park
Journal:  Cerebellum       Date:  2012-09       Impact factor: 3.847

6.  Population genetics and new insight into range of CAG repeats of spinocerebellar ataxia type 3 in the Han Chinese population.

Authors:  Shi-Rui Gan; Wang Ni; Yi Dong; Ning Wang; Zhi-Ying Wu
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

7.  Expansion of the Spinocerebellar ataxia type 10 (SCA10) repeat in a patient with Sioux Native American ancestry.

Authors:  Khalaf Bushara; Matthew Bower; Jilin Liu; Karen N McFarland; Ivette Landrian; Diane Hutter; Hélio A G Teive; Astrid Rasmussen; Connie J Mulligan; Tetsuo Ashizawa
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.